BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 115663)

  • 1. An approach to the restoration of T cell function in a purine nucleoside phosphorylase deficient patient.
    Zegers BJ; Stoop JW; Staal GE; Wadman SK
    Ciba Found Symp; 1978; (68):231-53. PubMed ID: 115663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine nucleoside phosphorylase deficiency: improved metabolic and immunologic function with erythrocyte transfusions.
    Rich KC; Majias E; Fox IH
    N Engl J Med; 1980 Oct; 303(17):973-7. PubMed ID: 6774252
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes.
    Staal GE; Stoop JW; Zegers BJ; Siegenbeek van Heukelom LH; van der Vlist MJ; Wadman SK; Martin DW
    J Clin Invest; 1980 Jan; 65(1):103-8. PubMed ID: 6765955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.
    Stoop JW; Zegers BJ; Hendrickx GF; van Heukelom LH; Staal GE; de Bree PK; Wadman SK; Ballieux RE
    N Engl J Med; 1977 Mar; 296(12):651-5. PubMed ID: 402573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.
    Cohen A; Doyle D; Martin DW; Ammann AJ
    N Engl J Med; 1976 Dec; 295(26):1449-54. PubMed ID: 825775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine nucleoside phosphorylase deficiency: biochemical properties and heterogeneity in two families.
    Wortmann RL; Andres C; Kaminska J; Mejias E; Gelfand E; Arnold W; Rich K; Fox IH
    Arthritis Rheum; 1979 May; 22(5):524-31. PubMed ID: 36100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Purine nucleoside phosphorylase deficiency. Report of two cases].
    Barrio Corrales F; Madero L; Zabay JM; Ludeña MC; Gómez de la Concha E; Lozano C; Sainz T
    An Esp Pediatr; 1983 Mar; 18(3):248-53. PubMed ID: 6410951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 10. Purine nucleoside phosphorylase (PNP) deficiency: a therapeutic challenge.
    Watson AR; Simmonds HA; Webster DR; Layward L; Evans DI
    Adv Exp Med Biol; 1984; 165 Pt A():53-9. PubMed ID: 6426259
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial purine nucleoside phosphorylase deficiency. Studies of lymphocyte function.
    Gelfand EW; Dosch HM; Biggar WD; Fox IH
    J Clin Invest; 1978 Apr; 61(4):1071-80. PubMed ID: 96131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of orotic acid, orotidine and other pyrimidines in a patient with purine nucleoside phosphorylase deficiency.
    van Gennip AH; Grift J; de Bree PK; Zegers BJ; Stoop JW; Wadman SK
    Clin Chim Acta; 1979 May; 93(3):419-28. PubMed ID: 109238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
    Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
    J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired defense against vaccinia in a child with T-lymphocyte deficiency associated with inosine phosphorylase defect.
    Virelizier JL; Hamet M; Ballet JJ; Reinert P; Griscelli C
    J Pediatr; 1978 Mar; 92(3):358-62. PubMed ID: 416187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular immune deficiency with autoimmune hemolytic anemia in purine nucleoside phosphorylase deficiency.
    Rich KC; Arnold WJ; Palella T; Fox IH
    Am J Med; 1979 Jul; 67(1):172-6. PubMed ID: 111549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
    Markert ML; Hershfield MS; Schiff RI; Buckley RH
    J Clin Immunol; 1987 Sep; 7(5):389-99. PubMed ID: 3116034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second case of inosine phosphorylase deficiency with severe T-cell abnormalities.
    Hamet M; Griscelli C; Cartier P; Ballay J; de Bruyn C; Hösli P
    Adv Exp Med Biol; 1977; 76A():477-80. PubMed ID: 404854
    [No Abstract]   [Full Text] [Related]  

  • 19. Purine nucleoside phosphorylase deficiency. Evidence for molecular heterogeneity in two families with enzyme-deficient members.
    Osborne WR; Chen SH; Giblett ER; Biggar WD; Ammann AA; Scott CR
    J Clin Invest; 1977 Sep; 60(3):741-6. PubMed ID: 408378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.